
India’s first COVID-19 vaccine gets clearance for human clinical trials
Web Desk India’s first COVID-19 vaccine COVAXIN has got the Drug Controller General of India’s approval for phase I and II of human clinical trials.
Web Desk India’s first COVID-19 vaccine COVAXIN has got the Drug Controller General of India’s approval for phase I and II of human clinical trials.